Ivan Titov
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Obstructive Sleep Apnea Research 3
- Co-authors
- Helen W. Boucher (1 shared paper)Richard G. Wunderink (1 shared paper)Robert Tipping (1 shared paper)Munjal Patel (1 shared paper)Maria C Losada (1 shared paper)Aileen David-Wang (1 shared paper)Jiejun Du (1 shared paper)Michelle L. Hoffman Brown (1 shared paper)
- Journals
- The Lancet Infectious Diseases (1 paper)New England Journal of Medicine (1 paper)Open Forum Infectious Diseases (1 paper)Clinical Infectious Diseases (1 paper)Pirogov Russian Journal of Surgery (1 paper)
- Partner nations
- UkraineUnited StatesSpain
In The Last Decade
Ivan Titov
5 papers receiving 336 citations
Ivan Titov's Hit Papers
Peers
Comparison fields: 5 of 47
- Applied Microbiology and Biotechnology 74
- Molecular Medicine 180
- Pharmacology 101
- Critical Care and Intensive Care Medicine 29
- Clinical Biochemistry 21
Countries citing papers authored by Ivan Titov
This map shows the geographic impact of Ivan Titov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan Titov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan Titov more than expected).
Fields of papers citing papers by Ivan Titov
This network shows the impact of papers produced by Ivan Titov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan Titov. The network helps show where Ivan Titov may publish in the future.
Co-authors
The 19 scholars most cited alongside Ivan Titov, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 169 | |
| 2 | Aztreonam–avibactam versus meropenem for the treatment of serious infections caused by Gram-negative bacteria (REVISIT): a descriptive, multinational, open-label, phase 3, randomised trial Hit paper breakdown → | 2024 | 75 |
| 3 | 2023 | 69 | |
| 4 | 2023 | 25 | |
| 5 | 2018 | 1 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 0 | |
| 8 | 2025 | 0 | |
| 9 | 2024 | 0 |
About Ivan Titov
Ivan Titov is a scholar working on Physiology, Applied Microbiology and Biotechnology, Cardiology and Cardiovascular Medicine, Molecular Medicine and Neurology, having authored 9 papers that have together received 339 indexed citations. Recurring topics across this work include Obstructive Sleep Apnea Research (3 papers), Acute Ischemic Stroke Management (1 paper), Healthcare Systems and Public Health (1 paper), Heart Rate Variability and Autonomic Control (1 paper), Antibiotics Pharmacokinetics and Efficacy (1 paper), Cardiovascular Syncope and Autonomic Disorders (1 paper), Abdominal Trauma and Injuries (1 paper) and Antibiotic Resistance in Bacteria (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (74 citations), Molecular Medicine (180 citations), Pharmacology (101 citations), Critical Care and Intensive Care Medicine (29 citations) and Clinical Biochemistry (21 citations). Ivan Titov has collaborated with scholars based in Ukraine, United States and Spain. Frequent co-authors include Helen W. Boucher, Richard G. Wunderink, Robert Tipping, Munjal Patel, Maria C Losada, Aileen David-Wang, Jiejun Du, Michelle L. Hoffman Brown, Amanda A. Paschke and Antoine Roquilly. Their work appears in journals such as The Lancet Infectious Diseases, New England Journal of Medicine, Open Forum Infectious Diseases, Clinical Infectious Diseases and Pirogov Russian Journal of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.